Annual report pursuant to Section 13 and 15(d)

Financial Instruments and Risk - Additional Information (Detail)

v3.24.1
Financial Instruments and Risk - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Concentration Risk [Line Items]    
Cash $ 400  
Cash equivalents $ 14,252 $ 22,756
Average days to maturity of Company's portfolio of cash equivalents and marketable securities 0 days  
Sweep Account [Member]    
Concentration Risk [Line Items]    
Cash equivalents $ 2,400  
Maximum [Member]    
Concentration Risk [Line Items]    
Maturity period of securities 1 year